ReviewGlobal health & medicine2024
Aging populations and perspectives of geriatric medicine in Japan.
Review in Global health & medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Safety and Efficacy of Microhook Ab Interno Trabeculotomy Combined with Cataract Surgery in Older Patients with Glaucoma.Ophthalmology and therapy · 2026Article
- Primary care physician characteristics and potentially inappropriate medications in older adults.Health affairs scholar · 2026Article
- Advancing Geriatric Care in Japan: Integrating the 5Ms Framework With Comprehensive Geriatric Assessment for Enhanced Clinical Practice in a Super-Aged Society.Geriatrics & gerontology international · 2026Article
- Frailty Transforms Care Continuity-Mortality Relationships Across Age Groups: Evidence From Taiwan and South Korea.Journal of cachexia, sarcopenia and muscle · 2026Article
- Functional Independence Measure assessed early after admission predicts home discharge in older adults admitted to acute general medical wards: a retrospective cohort study.Family medicine and community health · 2026Observational
- Japan's high-quality healthcare system despite physician shortages: Exploring the paradox and pathways toward sustainable healthcare.Global health & medicine · 2026Review
- Feasibility of a Cinematic-Virtual Reality Program Educating Health Professional Students About the Complexity of Geriatric Care: Pilot Pre-Post Study.JMIR aging · 2025Article
- The present and future of geriatric internal medicine: a bibliometric analysis.Frontiers in medicine · 2025Review
- Defining the role and reach of a geriatrician.The lancet. Healthy longevity · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It is well known that Japan's population is aging, and the number of people older than 75 years is increasing significantly. Since older people, especially old individuals, are often multimorbid and cannot be always successfully treated and cared for by individual organ-specific treatment, it is essential to utilize knowledge of geriatrics when treating such older patients. Therefore, it is indisputable that education on geriatric medicine is extremely important in Japan, which is the country with the largest aging population. However, the number of universities in Japan that offer geriatrics courses is decreasing. This means that many medical students become doctors without learning the essential characteristics of medical care for older patients despite the need for prompt treatment of older patients in clinical practice in Japan, which is a major obstacle to the development of geriatric medicine in Japan. Here, we review the current status of geriatrics in Japan and overseas and consider the future of geriatrics education to provide holistic and cost-effective medical care for older patients and improve their quality of life and well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.